ondansetron has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bektas, N | 1 |
| Arslan, R | 1 |
| Ozturk, Y | 1 |
| Bossi, A | 1 |
| Baresi, A | 1 |
| Ballini, A | 1 |
| Bindelli, C | 1 |
2 other studies available for ondansetron and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Zonisamide: Antihyperalgesic efficacy, the role of serotonergic receptors on efficacy in a rat model for painful diabetic neuropathy.
Topics: Animals; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Disease Models, Animal; Dose-Respons | 2014 |
Ondasentron in the treatment of diabetic diarrhea.
Topics: Diabetes Mellitus, Type 1; Diabetic Neuropathies; Diarrhea; Glycated Hemoglobin; Humans; Male; Middl | 1994 |